Quarterly report pursuant to Section 13 or 15(d)

Description of Business (Details Narrative)

v3.23.1
Description of Business (Details Narrative) - USD ($)
1 Months Ended
Jun. 25, 2021
Jun. 09, 2021
Sep. 30, 2021
Mar. 31, 2023
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]          
Number of shares returned for cancellation   14,465,259      
Series A-1 Preferred Stock [Member]          
Restructuring Cost and Reserve [Line Items]          
Stated value per share       $ 0.0001 $ 0.0001
Series A-1 Preferred Stock [Member] | Mr. Gerard Dab [Member]          
Restructuring Cost and Reserve [Line Items]          
Debt Conversion, Converted Instrument, Shares Issued   1,000      
Debt Conversion, Original Debt, Amount   $ 300,000      
[custom:VotingPercent-0]   51.00%      
Series C-1 Preferred Stock [Member] | Mr. Gerard Dab [Member]          
Restructuring Cost and Reserve [Line Items]          
Number of shares issued on acquisition   200      
Number of shares exchanged   $ 200,000      
Fair market value of shares   $ 122,000      
Rennova Health Inc. [Member] | Series B-1 Preferred Stock [Member]          
Restructuring Cost and Reserve [Line Items]          
Number of shares issued 14,000   950    
Stated value per share $ 1,000        
Percentage of shares for conversion 4.99%